Chief Strategic Officer
You might think that it’s John's Kiwi accent (yes, he’s a New Zealander) that makes you want to listen to him and believe everything he says. But then you realize the guy has over 20 years of oncology experience spanning liquid and solid tumors, colon, lung, breast, prostate, pancreatic, esophageal, liver, ovarian, head and neck, myeloma, CLL, DLBC, and follicular lymphoma, among others. Of course you’re going to pay attention to what he has to say.
John has been the Chief Strategic Officer at WILDTYPE for the past 4 and a half years and currently oversees the whole Merck oncology portfolio. Hardly a day goes by that you don’t see him excited about a new trial, a new breakthrough, or a unique solution he’s helped to create for one of his clients. He’s truly passionate about oncology.
John may still be Kiwi through and through, but he’s now a New Jersey boy, along with his family, dogs, cats, and squirrels.